DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Taspoglutide is an investigational drug.
There have been 13 clinical trials for Taspoglutide. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2008.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Cardiovascular Diseases. The leading clinical trial sponsors are Hoffmann-La Roche and [disabled in preview].
Recent Clinical Trials for Taspoglutide
|A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease||Hoffmann-La Roche||Phase 3|
|A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy||Hoffmann-La Roche||Phase 3|
|A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes||Hoffmann-La Roche||Phase 3|